{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:57:53Z","timestamp":1790996273549,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disorder characterized by motor symptoms such as bradykinesia, rigidity, and tremor. Despite its prevalence, genetic and epigenetic studies in the Mexican Mestizo population (individuals of mixed Indigenous and European\u2014primarily Spanish\u2014ancestry who represent the majority demographic in Mexico) remain limited. DNA methylation may play a role in PD pathogenesis, with peripheral blood methylation patterns serving as potential biomarkers. This study examines <jats:italic>MAPT<\/jats:italic> and <jats:italic>SNCA<\/jats:italic> gene methylation in Mexican PD patients to identify epigenetic alterations associated with the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this case-control study, we enrolled 108 PD patients and 108 age- and sex matched controls from Mexico City and Durango. Genomic DNA was extracted from leukocytes, and bisulfite pyrosequencing was performed to assess methylation levels at specific CpG sites within <jats:italic>MAPT<\/jats:italic> and <jats:italic>SNCA<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our analysis revealed a significant reduction in global methylation levels in the <jats:italic>MAPT<\/jats:italic> promoter region and <jats:italic>SNCA<\/jats:italic> intron 1 in PD patients compared to controls (<jats:italic>MAPT<\/jats:italic>, <jats:italic>p<\/jats:italic> =\u202f0.0019; <jats:italic>SNCA<\/jats:italic>, <jats:italic>p<\/jats:italic> =\u202f0.000069). Site-specific analysis showed significant hypomethylation at <jats:italic>MAPT<\/jats:italic> CpG sites 1, 4, 10\u201311 and at <jats:italic>SNCA<\/jats:italic> CpG sites 1\u20133, 5\u20137 and, 25 in PD cases. Regional analysis (central and northern M\u00e9xico) revealed significant differences in <jats:italic>MAPT<\/jats:italic> methylation between PD patients and controls exclusively in the northern region (<jats:italic>p<\/jats:italic> =\u202f0.0039) and in <jats:italic>SNCA<\/jats:italic> methylation only in the central region (<jats:italic>p<\/jats:italic> =\u202f0.00001). Gender-based stratification indicated that <jats:italic>MAPT<\/jats:italic> methylation was significantly different in men (<jats:italic>p<\/jats:italic> =\u202f0.0013), whereas <jats:italic>SNCA<\/jats:italic> methylation differences were significant only in women (<jats:italic>p<\/jats:italic> =\u202f0.00045). We found an association between global methylation patterns of <jats:italic>MAPT<\/jats:italic> (OR\u202f=\u202f1.182, 95% CI\u202f=\u202f1.029\u20131.197, <jats:italic>p<\/jats:italic> =\u202f0.007) and <jats:italic>SNCA<\/jats:italic> (OR\u202f=\u202f1.243, 95% CI\u202f=\u202f1.067\u20131.448, <jats:italic>p<\/jats:italic> =\u202f0.005) with PD. Gender-stratified regression showed that <jats:italic>MAPT<\/jats:italic> methylation was significantly associated with PD exclusively in men (OR\u202f=\u202f1.182, 95% CI\u202f=\u202f1.041\u20131.342, <jats:italic>p<\/jats:italic> =\u202f0.010), whereas <jats:italic>SNCA<\/jats:italic> methylation was significantly associated with PD only in women (OR\u202f=\u202f1.337, 95% CI\u202f=\u202f1.044\u20131.713, <jats:italic>p<\/jats:italic> =\u202f0.021).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings reveal significant <jats:italic>MAPT<\/jats:italic> and <jats:italic>SNCA<\/jats:italic> hypomethylation in PD patients within the Mexican Mestizo population. These epigenetic modifications may contribute to PD pathogenesis and highlight the potential of DNA methylation profiles as biomarkers for PD, particularly in regional- and gender-specific contexts. This study advances the understanding of PD\u2019s molecular mechanisms and underscores the importance of studying diverse populations to identify novel disease biomarkers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2025.1612544","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T05:46:36Z","timestamp":1752126396000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential methylation of SNCA and MAPT genes associated with Parkinson\u2019s disease in Mexican Mestizos"],"prefix":"10.3389","volume":"17","author":[{"given":"Ernesto G.","family":"Miranda-Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Ramos-Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma C.","family":"Salas-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio M.","family":"Salas-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco X.","family":"Castellanos-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna M.","family":"M\u00e9ndez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osmel","family":"La Llave-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda S.","family":"Pe\u00f1aherrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Qui\u00f1ones-Canales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Arias-Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada A.","family":"Sandoval-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Salas-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","article-title":"Hypomethylation of SNCA in blood of patients with sporadic Parkinson\u2019s disease","volume":"337","author":"Ai","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.21020","article-title":"Iron metabolism in parkinsonian syndromes","volume":"21","author":"Berg","year":"2006","journal-title":"Mov. Disord."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/mds.25784","article-title":"DNA methylation of the MAPT gene in Parkinson\u2019s disease cohorts and modulation by vitamin E in vitro","volume":"29","author":"Coupland","year":"2014","journal-title":"Mov. Disord."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3233\/JPD-230357","article-title":"Parkinson\u2019s disease is predominantly an environmental disease","volume":"14","author":"Dorsey","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jtemb.2016.03.010","article-title":"Iron chelation in the treatment of neurodegenerative diseases","volume":"38","author":"Dusek","year":"2016","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/epigenomes7010005","article-title":"SNCA gene methylation in Parkinson\u2019s disease and multiple system atrophy","volume":"7","author":"Fedotova","year":"2023","journal-title":"Epigenomes"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11306-024-02181-4","article-title":"Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease","volume":"20","author":"Flores-Ponce","year":"2024","journal-title":"Metabolomics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/npjparkd.2016.21","article-title":"Defining a role for hemoglobin in Parkinson\u2019s disease","volume":"2","author":"Freed","year":"2016","journal-title":"npj Parkinsons Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"652226","DOI":"10.3389\/fnins.2021.652226","article-title":"Cell-type specific changes in DNA methylation of SNCA intron 1 in synucleinopathy brains","volume":"15","author":"Gu","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13041-017-0285-z","article-title":"Hypomethylation of intron1 of \u03b1-synuclein gene does not correlate with Parkinson\u2019s disease","volume":"10","author":"Guhathakurta","year":"2017","journal-title":"Mol. Brain"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson\u2019s disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e62969","DOI":"10.1371\/journal.pone.0062969","article-title":"Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placenta","volume":"8","author":"Hogg","year":"2013","journal-title":"PLoS One"},{"key":"ref17","article-title":"Rapid extraction of high quality DNA from whole blood stored at 4\u00b0C for long period","author":"Iranpur","year":"2010"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients\u2019 brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","article-title":"Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease","volume":"56","author":"Kim","year":"2024","journal-title":"Nat. Genet."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2016.06.008","article-title":"Uncovering the role of the methylome in dementia and neurodegeneration","volume":"22","author":"Klein","year":"2016","journal-title":"Trends Mol. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"635923","DOI":"10.1155\/2014\/635923","article-title":"Peripheral leukocyte apoptosis in patients with parkinsonism: correlation with clinical characteristics and neuroimaging findings","volume":"2014","author":"Lin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuroimage.2015.06.012","article-title":"Hippocampal volume and functional connectivity changes during the female menstrual cycle","volume":"118","author":"Lisofsky","year":"2015","journal-title":"NeuroImage"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnins.2019.00114","article-title":"Nitric oxide, iron and neurodegeneration","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/jhg.2012.67","article-title":"Admixture and population structure in Mexican-Mestizos based on paternal lineages","volume":"57","author":"Mart\u00ednez-Cort\u00e9s","year":"2012","journal-title":"J. Hum. Genet."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","article-title":"Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes","volume":"8","author":"Masliah","year":"2013","journal-title":"Epigenetics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/ijerph13090881","article-title":"Environmental exposures and Parkinson\u2019s disease","volume":"13","author":"Nandipati","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41531-023-00580-3","article-title":"Ethnicity- and sex-specific genome wide association study on Parkinson\u2019s disease","volume":"9","author":"Park","year":"2023","journal-title":"npj Parkinsons Dis"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fncel.2016.00096","article-title":"Genetic architecture of MAPT gene region in Parkinson disease subtypes","volume":"10","author":"Pascale","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41531-021-00196-5","article-title":"A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson\u2019s disease","volume":"7","author":"Pedersen","year":"2021","journal-title":"npj Parkinsons Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/mds.26073","article-title":"Parkinson\u2019s disease correlates with promoter methylation in the alpha-synuclein gene","volume":"30","author":"Pihlstrom","year":"2015","journal-title":"Mov. Disord."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-021-00157-y","article-title":"Differences in MTHFR and LRRK2 variant\u2019s association with sporadic Parkinson\u2019s disease in Mexican Mestizos correlated to native American ancestry","volume":"7","author":"Romero-Gutierrez","year":"2021","journal-title":"npj Parkinsons Dis."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"135901","DOI":"10.1016\/j.neulet.2021.135901","article-title":"Alpha-syn and SNP rs356219 as a potential biomarker in blood for Parkinson\u2019s disease in Mexican Mestizos","volume":"754","author":"Salas-Leal","year":"2021","journal-title":"Neurosci. Lett."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1298560","DOI":"10.3389\/fnmol.2023.1298560","article-title":"Differential expression of PSMC4, SKP1, and HSPA8 in Parkinson's disease: insights from a Mexican Mestizo population","volume":"16","author":"Salas-Leal","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fneur.2019.01066","article-title":"rs3764435 associated with Parkinson\u2019s disease in Mexican Mestizos: case-control study reveals protective effects against disease development and cognitive impairment","volume":"10","author":"Salas-Leal","year":"2019","journal-title":"Front. Neurol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"971298","DOI":"10.3389\/fgene.2022.971298","article-title":"DNA methylation as a mediator of genetic and environmental influences on Parkinson\u2019s disease susceptibility: impacts of alpha-synuclein, physical activity, and pesticide exposure on the epigenome","volume":"13","author":"Schaffner","year":"2022","journal-title":"Front. Genet."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/mds.22139","article-title":"Uric acid in Parkinson\u2019s disease","volume":"23","author":"Schlesinger","year":"2008","journal-title":"Mov. Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/mds.26319","article-title":"L-dopa increases alpha-synuclein DNA methylation in Parkinson\u2019s disease patients in vivo and in vitro","volume":"30","author":"Schmitt","year":"2015","journal-title":"Mov. Disord."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson\u2019s disease","volume":"118","author":"Sian-Hulsmann","year":"2011","journal-title":"J. Neurochem."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.1073\/pnas.0903045106","article-title":"Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico","volume":"106","author":"Silva-Zolezzi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e8856","DOI":"10.1371\/journal.pone.0008856","article-title":"Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease","volume":"5","author":"Simunovic","year":"2010","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(09)70262-5","article-title":"Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies","volume":"8","author":"Urdinguio","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.hgmx.2015.10.006","article-title":"Current treatments in Parkinson's including the proposal of an innovative dopamine microimplant","volume":"79","author":"Vel\u00e1zquez-Paniagua","year":"2016","journal-title":"Rev. M\u00e9d. Hosp. Gen. M\u00e9xico"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/acs.biomac.6b01547","article-title":"Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson disease","volume":"18","author":"Wang","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/qjmed\/95.10.691","article-title":"Uric acid: an important antioxidant in acute ischaemic stroke","volume":"95","author":"Waring","year":"2002","journal-title":"QJM"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e0173731","DOI":"10.1371\/journal.pone.0173731","article-title":"Serum uric acid levels in patients with Parkinson\u2019s disease: a meta-analysis","volume":"12","author":"Wen","year":"2017","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fneur.2018.00809","article-title":"Tau pathology in Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Neurol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fnmol.2018.00391","article-title":"A comprehensive analysis of the association between SNCA polymorphisms and the risk of Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2018","journal-title":"Front. Mol. Neurosci."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1612544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:37:14Z","timestamp":1752154634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1612544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":48,"alternative-id":["10.3389\/fnagi.2025.1612544"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1612544","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"article-number":"1612544"}}